Bivalirudin vs. Enoxaparin in Intubated COVID-19 Patients: A Pilot Multicenter Randomized Controlled Trial

(1) Background: In COVID-19 patients, the occurrence of thromboembolic complications contributes to disease progression and mortality. In patients at increased risk for thrombotic complications, therapeutic enoxaparin should be considered. However, critically ill COVID-19 patients could develop resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Garofalo, Eugenio, Cammarota, Gianmaria, Neri, Giuseppe, Macheda, Sebastiano, Biamonte, Eugenio, Pasqua, Pino, Guzzo, Maria Laura, Longhini, Federico, Bruni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604898/
https://www.ncbi.nlm.nih.gov/pubmed/36294312
http://dx.doi.org/10.3390/jcm11205992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604898/
https://www.ncbi.nlm.nih.gov/pubmed/36294312
http://dx.doi.org/10.3390/jcm11205992

Ejemplares similares